We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.

ORFADIN nitisinone 4 mg/mL oral suspension bottle (297736)

ARTG ID 297736

ARTG Name

ORFADIN nitisinone 4 mg/mL oral suspension bottle

Product name

ORFADIN nitisinone 4 mg/mL oral suspension bottle

ARTG Date

26 February 2019

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

nitisinone

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

ORFADIN nitisinone 4 mg/mL oral suspension bottle, A Menarini Australia Pty Ltd , CON-1303

16 December 2024

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 16 December 2024 until 30 September 2026.
ORFADIN nitisinone 4 mg/mL oral suspension bottle, A Menarini Australia Pty Ltd , CON-1337

19 March 2025

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 19 March 2025 until 30 June 2026.
ORFADIN nitisinone 4 mg/mL oral suspension bottle, A Menarini Australia Pty Ltd , CON-1418

9 October 2025

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 9 October 2025 until 30 September 2026.
ORFADIN nitisinone 4 mg/mL oral suspension bottle, A Menarini Australia Pty Ltd, CON-758

3 February 2021

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective from 3 February 2021 until 1 October 2026.
ORFADIN nitisinone 4 mg/mL oral suspension bottle, A Menarini Australia Pty Ltd, CON-758

3 February 2021

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective from 3 February 2021 until 1 October 2026.

Is there anything wrong with this page?

Help us improve